LAURUSLABS

Laurus Labs Limited

Healthcare

A research-driven pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients for anti-retroviral, oncology, cardiovascular, and gastroenterology therapies with global leadership positions in select segments. Laurus Labs operates multiple facilities approved by major regulatory agencies including USFDA, WHO-Geneva, EMA, and others. The company provides integrated contract manufacturing and development services to international pharmaceutical innovators across clinical development through commercial production stages.

Investors holding Laurus Labs Limited

American Funds (Capital Group)

Foreign Investor

4.28%

Barclays

Foreign Investor

1.55%

Akash Bhanshali

Investor

1.32%

Kotak Offshore

Foreign Investor

1.01%

Latest move